Staphylococcus aureus Exploits Epidermal Barrier Defects in Atopic Dermatitis to Trigger Cytokine Expression

Area of Science:

• Dermatology
• Microbiology
• Immunology

Background:

• Patients with atopic dermatitis (AD) exhibit a compromised skin barrier.
• Frequent colonization by Staphylococcus aureus is common in AD.
• The interaction between S. aureus and the AD skin barrier requires further investigation.

Purpose of the Study:

• To investigate S. aureus penetration of the epidermal barrier in AD.
• To understand the mechanisms and functional significance of S. aureus dermal entry.
• To explore the relationship between S. aureus entry and AD-associated cytokines.

Main Methods:

• Observation of S. aureus in lesional skin from AD patients.
• Experiments using cultured human skin equivalents and mouse models.
• Assessment of bacterial viability and protease activity for penetration.
• Analysis of cytokine and cathelicidin expression.

Main Results:

• S. aureus was more abundant in the dermis of lesional AD skin.
• Bacterial entry was increased in cathelicidin knockout and filaggrin mutant mice.
• Penetration required viable, protease-active S. aureus.
• S. aureus entry correlated with increased IL-4, IL-13, IL-22, thymic stromal lymphopoietin, and decreased cathelicidin.

Conclusions:

• Epidermal barrier abnormalities in AD facilitate S. aureus dermal entry.
• This entry contributes to increased inflammatory cytokines and disease exacerbation.
• Altered S. aureus-skin interaction represents a key aspect of AD pathogenesis.